UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

P06.08.B Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii39-ii39

2022

Volltextzugriff (PDF)

Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition-Associated Checkpoint Abrogation

Molecular cancer research, 2015-12, Vol.13 (12), p.1544-1553

2015

Volltextzugriff (PDF)

THU-039 - Direct and indirect hepatoprotective mechanism of CBLB502 a TLR5 agonist

Journal of hepatology, 2018-04, Vol.68, p.S140-S141

2018

Volltextzugriff (PDF)

Direct and indirect hepatoprotective mechanism of CBLB502 a TLR5 agonist

Journal of hepatology, 2018-04, Vol.68, p.S140-S141

2018

Volltextzugriff (PDF)

The role of MET in tumor resistance to radiation therapy: a phosphoproteomic approach

European journal of cancer (1990), 2016-07, Vol.61, p.S157-S157

2016

Volltextzugriff (PDF)

DC pension fund benchmarking with fixed-mix portfolio optimization

Quantitative finance, 2007-08, Vol.7 (4), p.365-370

2007

Volltextzugriff (PDF)

Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer

European journal of cancer (1990), 2016-07, Vol.61, p.S161-S162

2016

Volltextzugriff (PDF)

Investigating a novel potential ATM/ATR/DNA-PK phosphorylation site on the MET RTK as a link between MET addiction and radioresistance

European journal of cancer (1990), 2016-07, Vol.61, p.S162-S162

2016

Volltextzugriff (PDF)

Separation and detection of oxidation products of fluorodeoxyglucose and glucose by high-performance liquid chromatography–electrospray ionisation mass spectrometry

Journal of Chromatography A, 2004-04, Vol.1034 (1), p.133-137

2004

Volltextzugriff (PDF)

MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest

Genes & cancer, 2010-10, Vol.1 (10), p.1053-1062

2010

Volltextzugriff (PDF)

PO-1446 Systematic Review of Prognostic and Predictive Biomarkers in HNSCC Treated with Radiotherapy

Radiotherapy and oncology, 2023-05, Vol.182, p.S1170-S1171

2023

Volltextzugriff (PDF)

720 - Investigating a novel potential ATM/ATR/DNA-PK phosphorylation site on the MET RTK as a link between MET addiction and radioresistance

European journal of cancer (1990), 2016-07, Vol.61, p.S162-S162

2016

Volltextzugriff (PDF)

702 - The role of MET in tumor resistance to radiation therapy: a phosphoproteomic approach

European journal of cancer (1990), 2016-07, Vol.61, p.S157-S157

2016

Volltextzugriff (PDF)

Influence of KfoG on capsular polysaccharide structure in Escherichia coli K4 strain

Molecular biotechnology, 2005-06, Vol.30 (2), p.129-134

2005

Volltextzugriff (PDF)

719 - Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer

European journal of cancer (1990), 2016-07, Vol.61, p.S161-S162

2016

Volltextzugriff (PDF)

High-Performance Computing in Finance: Problems, Methods, and Solutions

1, 2018

Volltextzugriff (PDF)

Comparative Analysis of the Russian and Australian Legislation on Toxic Gases after Blasting

E3S Web of Conferences, 2021, Vol.266, p.3004

2021

Volltextzugriff (PDF)

MET targeting: time for a rematch

Oncogene, 2020-04, Vol.39 (14), p.2845-2862

2020

Volltextzugriff (PDF)

CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks

Molecular cancer, 2023-05, Vol.22 (1), p.82-82, Article 82

2023

Volltextzugriff (PDF)

Abstract PO-039: Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy approach for glioblastoma multiforme

Clinical cancer research, 2021-04, Vol.27 (8_Supplement), p.PO-039-PO-039

2021

Volltextzugriff (PDF)

DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions

Pharmacology & therapeutics (Oxford), 2020-11, Vol.215, p.107617-107617, Article 107617

2020

Volltextzugriff (PDF)

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer

Molecular cancer, 2018-02, Vol.17 (1), p.27-27, Article 27

2018

Volltextzugriff (PDF)

Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma

Cell death & disease, 2019-10, Vol.10 (10), p.749-17, Article 749

2019

Volltextzugriff (PDF)

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Neurology, 2016-09, Vol.87 (10), p.978

2016

Volltextzugriff (PDF)

ProtRank: bypassing the imputation of missing values in differential expression analysis of proteomic data

BMC bioinformatics, 2019-11, Vol.20 (1), p.563-12, Article 563

2019

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

P06.08.B Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy for glioblastoma

Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition-Associated Checkpoint Abrogation

THU-039 - Direct and indirect hepatoprotective mechanism of CBLB502 a TLR5 agonist

Direct and indirect hepatoprotective mechanism of CBLB502 a TLR5 agonist

The role of MET in tumor resistance to radiation therapy: a phosphoproteomic approach

DC pension fund benchmarking with fixed-mix portfolio optimization

Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer

Investigating a novel potential ATM/ATR/DNA-PK phosphorylation site on the MET RTK as a link between MET addiction and radioresistance

Separation and detection of oxidation products of fluorodeoxyglucose and glucose by high-performance liquid chromatography–electrospray ionisation mass spectrometry

MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest

PO-1446 Systematic Review of Prognostic and Predictive Biomarkers in HNSCC Treated with Radiotherapy

720 - Investigating a novel potential ATM/ATR/DNA-PK phosphorylation site on the MET RTK as a link between MET addiction and radioresistance

702 - The role of MET in tumor resistance to radiation therapy: a phosphoproteomic approach

Influence of KfoG on capsular polysaccharide structure in Escherichia coli K4 strain

719 - Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer

High-Performance Computing in Finance: Problems, Methods, and Solutions

Comparative Analysis of the Russian and Australian Legislation on Toxic Gases after Blasting

MET targeting: time for a rematch

CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks

Abstract PO-039: Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy approach for glioblastoma multiforme

DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer

Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

ProtRank: bypassing the imputation of missing values in differential expression analysis of proteomic data

Suchergebnisse filtern